Keywords
Microbiome
TLR
NOD
RIG-1
How to Cite
Abstract
The microbiome plays a crucial role in controlling viral infections like the Human Papillomavirus. Getting infected by HPV is not always necessary or not sufficient for the progression of cervical cancer. According to many kinds of research, it was shown that the presence of Human papillomavirus infection is not always connected to the abundance of Lactobacilli and L. gasseri. Besides that some research data suggests an association of cervicovaginal microbiome to viral infections, there are very few things clear about the exact role of the microbiome in carcinogeneses and also about mechanisms and consequences, which are responsible for the HVP persistence and elimination. Recently there are invoked some theoretical models about the Virus-Bacteria-host organism interaction and virus-associated neoplasms are classified into five major types. The characteristics, features and variability of how the cervical epithelial cells maintain to discover various types of pathogen configuration receptors are still under research such as pathogen configuration detection receptors toll-like receptor family (TLR), Retinoic acid-inducible gene 1 (RIG-1) and Nod-like receptor family (NOD). There is a lot more to study thoroughly about how all of these receptors are functioning in virus inducible lesions and what kinds of influences do they have on virus persistence and neoplastic progression.
References
Arbyn M, Weiderpass E, Bruni L, et al. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis [published correction appears in Lancet Glob Health. 2022 Jan;10(1):e41]. Lancet Glob Health. 2020;8(2):e191-e203. doi:10.1016/S2214-109X(19)30482-6
Joura EA, Giuliano AR, Iversen OE, Bouchard C, Mao C, Mehlsen J, Moreira Jr ED, Ngan Y, Petersen LK, Lazcano-Ponce E, Pitisuttithum P. A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women. New England Journal of Medicine. 2015 Feb 19;372(8):711-23.
Arbyn M, Xu L, Simoens C, Martin‐Hirsch PP. Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors. Cochrane database of systematic reviews. 2018(5).
Curty G, de Carvalho PS, Soares MA. The Role of the Cervicovaginal Microbiome on the Genesis and as a Biomarker of Premalignant Cervical Intraepithelial Neoplasia and Invasive Cervical Cancer. Int J Mol Sci. 2019;21(1):222. Published 2019 Dec 28. doi:10.3390/ijms21010222
Shulzhenko, Natalia, et al. "Menage a trois: an evolutionary interplay between human papillomavirus, a tumor, and a woman." Trends in microbiology 22.6 (2014): 345-353.
Garrett, Wendy S. "Cancer and the microbiota." Science 348.6230 (2015): 80-86.
Bhatt, Aadra P., Matthew R. Redinbo, and Scott J. Bultman. "The role of the microbiome in cancer development and therapy." CA: a cancer journal for clinicians 67.4 (2017): 326-344.
Rajagopala, S. V., Vashee, S., Oldfield, L. M., Suzuki, Y., Venter, J. C., Telenti, A., & Nelson, K. E. (2017). The human microbiome and cancer. Cancer Prevention Research, 10(4), 226-234.
Ravel J, Gajer P, Abdo Z, Schneider GM, Koenig SS, McCulle SL, Karlebach S, Gorle R, Russell J, Tacket CO, Brotman RM. Vaginal microbiome of reproductive-age women. Proceedings of the National Academy of Sciences. 2011 Mar 15;108(Supplement 1):4680-7.
Ma, Bing, Larry J. Forney, and Jacques Ravel. "Vaginal microbiome: rethinking health and disease." Annual review of microbiology 66 (2012): 371-389.
Tachedjian G, Aldunate M, Bradshaw CS, Cone RA. The role of lactic acid production by probiotic Lactobacillus species in vaginal health. Research in microbiology. 2017 Nov 1;168(9-10):782-92.
Amabebe E, Anumba DO. The vaginal microenvironment: the physiologic role of lactobacilli. Frontiers in medicine. 2018 Jun 13;5:181.
Amabebe, Emmanuel, and Dilly OC Anumba. "The vaginal microenvironment: the physiologic role of lactobacilli." Frontiers in medicine 5 (2018): 181.
Vyshenska, D., Lam, K. C., Shulzhenko, N., & Morgun, A. (2017, August). Interplay between viruses and bacterial microbiota in cancer development. In Seminars in immunology (Vol. 32, pp. 14-24). Academic Press.
Gosmann, C., Anahtar, M.N., Handley, S.A., Farcasanu, M., Abu-Ali, G., Bowman, B.A., Padavattan, N., Desai, C., Droit, L., Moodley, A. and Dong, M., 2017. Lactobacillus-deficient cervicovaginal bacterial communities are associated with increased HIV acquisition in young South African women. Immunity, 46(1), pp.29-37.
Audirac-Chalifour, Astride, Kirvis Torres-Poveda, Margarita Bahena-Román, Juan Téllez-Sosa, Jesús Martínez-Barnetche, Bernardo Cortina-Ceballos, Guillermina López-Estrada et al. "Cervical microbiome and cytokine profile at various stages of cervical cancer: a pilot study." PloS one 11, no. 4 (2016): e0153274.
Shannon B, Yi TJ, Perusini S, Gajer P, Ma B, Humphrys MS, Thomas-Pavanel J, Chieza L, Janakiram P, Saunders M, Tharao W. Association of HPV infection and clearance with cervicovaginal immunology and the vaginal microbiota. Mucosal immunology. 2017 Sep;10(5):1310-9.
Zhang, C., Liu, Y., Gao, W., Pan, Y., Gao, Y., Shen, J., & Xiong, H. (2018). The direct and indirect association of cervical microbiota with the risk of cervical intraepithelial neoplasia. Cancer medicine, 7(5), 2172-2179.
Liss MA, White JR, Goros M, Gelfond J, Leach R, Johnson-Pais T, Lai Z, Rourke E, Basler J, Ankerst D, Shah DP. Metabolic biosynthesis pathways identified from fecal microbiome associated with prostate cancer. European urology. 2018 Nov 1;74(5):575-82.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright (c) 2022 Natia Adamashvili, Rima Beriashvili , George Burkadze